| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |